Links to all papers from the lab are organized by year of publication.

  • XYZeq: Spatially resolved single-cell RNA sequencing reveals expression heterogeneity in the tumor microenvironment, Science Advances, 2021 | Learn More
  • Evaluation of SARS-CoV-2 serology assays reveals a range of test performance, Nature Biotechnology, 2020 | Learn More
  • Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies, Cell, 2020 | Learn More
  • Functional CRISPR dissection of gene networks controlling human regulatory T cell identity, Nature Immunology, 2020 | Learn More
  • CRISPR screen in regulatory T cells reveals modulators of Foxp3, Nature, 2020 | Learn More
  • Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency, Nature Biotechnology, 2020 | Learn More
  • Rewired signaling network in T cells expressing the chimeric antigen receptor (CAR), EMBO J, 2020 | Learn More
  • Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair, Nature Communications, 2020 | Learn More
  • T cell subset-selective IL2RA enhancers shape autoimmune diabetes risk, bioRxiv, 2020 | Learn More
  • Efficient Generation of Isogenic Primary Human Myeloid Cells using CRISPR-Cas9 Ribonucleoproteins, bioRxiv, 2020 | Learn More
  • Landscape of stimulation-responsive chromatin across diverse human immune cells, Nature Genetics, 2019 | Learn More
  • Orthotopic replacement of T-cell receptor alpha and beta chains with preservation of near-physiological T-cell function, Nature Biomedical Engineering, 2019 | Learn More
  • CRISPR-Based Tools in Immunity, Annual Review of Immunology, 2019 | Learn More
  • Helios enhances the preferential differentiation of human fetal CD4+ naive T cells into regulatory T cells, Science Immunology, 2019 | Learn More
  • A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells, Immunity, 2019 | Learn More
  • Large dataset enables prediction of repair after CRISPR-Cas9 editing in primary T cells, Nature Biotechnology, 2019 | Learn More
  • A large CRISPR-induced bystander mutation causes immune dysregulation, Communications Biology, 2019 | Learn More
  • CRISPR-Cas9 genome engineering of primary CD4 + T cells for the interrogation of HIV-host factor interactions, Nature Protocols, 2019 | Learn More
  • Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function, Cell, 2018 | Learn More
  • Reprogramming human T cell function and specificity with non-viral genome targeting, Nature, 2018 | Learn More
  • CRISPR-Cas9 genome engineering of primary CD4 + T cells for the interrogation of HIV-host factor interactions, Nature Protocols, 2018 | Learn More
  • Multiplexed droplet single-cell RNA-sequencing using natural genetic variation, Nature Biotechnology, 2018 | Learn More
  • Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins, Journal of Immunological Methods, 2018 | Learn More
  • Discovery of stimulation-responsive immune enhancers with CRISPR activation, Nature, 2017 | Learn More
  • A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors, Nature Genetics, 2017 | Learn More
  • CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells, Scientific Reports, 2017 | Learn More
  • Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements, Nature Genetics, 2017 | Learn More
  • “T-bet”-ing on autoimmunity variants, PLOS Genetics, 2017 | Learn More

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells, Cell Reports, 2016 | Learn More

  • Genetic and epigenetic fine mapping of causal autoimmune disease variants, Nature, 2015 | Learn More
  • The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation, Immunity, 2015 | Learn More
  • Generation of knock-in primary human T cells using Cas9 ribonucleoproteins, PNAS, 2015 | Learn More
  • Genetic basis of autoimmunity, The Journal of Clinical Investigation, 2015 | Learn More
  • Small-molecule ROR-gamma-t antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms, Immunity, 2014 | Learn More
  • Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells, Cell, 2008 | Learn More
  • Wnt signaling promotes reprogramming of somatic cells to pluripotency, Cell Stem Cell, 2008 | Learn More
  • Foxp3 occupancy and regulation of key target genes during T-cell stimulation, Nature, 2007 | Learn More

Featured In


Media highlights of Alex and the lab’s research.
How CRISPR Tools are Unlocking New Ways to Fight Disease
Crispr: Breakthrough announced in technique of 'editing' DNA to fight off deadly illnesses
CRISPR-Based “Discovery Engine” for New Cell Therapies to Advance Cancer Treatments
With new genes and an electric shock, scientists turn immune cells against cancer
Swift Gene-Editing Method May Revolutionize Treatments for Cancer and Infectious Diseases
First Human Trial of Engineered T cells
In autoimmune diseases affecting millions, researchers pinpoint genetic risks, cellular culprits
Blunting CRISPR’s “scissors” gives new insight into autoimmune disorders
"Gentler” CRISPR sheds light on autoimmune disease
Engineering the Next Generation of Cell Therapies
Once Science Fiction, Gene Editing is Now a Looming Reality
Genetic Network that Differentiates Regulatory T Cells Mapped
Scientists map genes controlling immune system “brakes”
CRISPR identifies genes that might be targeted to hobble HIV infection
Antibody Test, Seen as Key to Reopening Country, Does Not Yet Deliver
Stellar Science Solving Cancer and COVID-19
Meet Dr. Alexander Marson, One of CRI’s New Lloyd J. Old STARs
The Immuno-Revolution: Resolving “Complexity Exemplified”
Gladstone launches 2 new institutes — one focused on Covid-19, the other on cell therapies
Two New Research Institutes in the Bay Area
Why DNA is the Most Exciting Programming Language Today
Coronavirus Antibody Tests: Can You Trust the Results?


Recent videos and interviews with Alex.
Alex appears on 60 minutes to discuss COVID-19 antibody testing
View Now >>
Alex discusses the COVID testing project on CNN
View Now >>
Science is Fun Podcast
View Now >>
American Society of Gene & Cell Therapy (ASGCT) Meeting
View Now >>

Stay Updated

Keep up-to-date with the latest research from the Marson lab.

At the Gladstone-UCSF Institute of Genomic Immunology, we're proud to be working toward a future ... #Immune2Cancer! @CancerResearch

#wearwhite #Immunotherapy @GladstoneInst @UCSFMedicine @parkerici

Big day for cell therapy! "Living therapeutics" use cells to restore tissue damaged by age or ... disease, super-charge the immune system to fight diseases, and more. @UCSF's new initiative means this cutting-edge medicine can reach patients faster. #ucsfLTI

Exciting new T cell surface proteomics with @realJimWells and @realJimWells led by @jrbyrnes8 and ... other wonderful collaborators. Lots of clues for followup and maybe new drug targets...

Schedule An Interview

Contact Jackie Sawin to schedule an interview with Alex Marson.